Package 62756-969-83

{"route": ["SUBLINGUAL"], "spl_id": "cbeda871-3722-4395-a97f-b614b5406675", "openfda": {"upc": ["0362756969834"], "unii": ["5Q187997EE", "56W8MW3EN1"], "rxcui": ["351266", "351267"], "spl_set_id": ["91b68606-05de-4586-ae31-07e8cc9160cf"], "manufacturer_name": ["Sun Pharmaceutical Industries, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "3 BLISTER PACK in 1 CARTON (62756-969-64)  / 10 TABLET in 1 BLISTER PACK", "package_ndc": "62756-969-64", "marketing_start_date": "20170718"}, {"sample": false, "description": "30 TABLET in 1 BOTTLE (62756-969-83)", "package_ndc": "62756-969-83", "marketing_start_date": "20170718"}], "brand_name": "Buprenorphine and Naloxone", "product_id": "62756-969_cbeda871-3722-4395-a97f-b614b5406675", "dosage_form": "TABLET", "pharm_class": ["Opioid Antagonist [EPC]", "Opioid Antagonists [MoA]", "Partial Opioid Agonist [EPC]", "Partial Opioid Agonists [MoA]"], "product_ndc": "62756-969", "dea_schedule": "CIII", "generic_name": "Buprenorphine and Naloxone", "labeler_name": "Sun Pharmaceutical Industries, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Buprenorphine and Naloxone", "active_ingredients": [{"name": "BUPRENORPHINE HYDROCHLORIDE", "strength": "2 mg/1"}, {"name": "NALOXONE HYDROCHLORIDE DIHYDRATE", "strength": ".5 mg/1"}], "application_number": "ANDA201633", "marketing_category": "ANDA", "marketing_start_date": "20170718", "listing_expiration_date": "20271231"}